Determination of atomoxetine levels in human plasma using LC-MS/MS and clinical application to Chinese children with ADHD based on CPIC guidelines-Reference-Cited by-同舟云学术

Determination of atomoxetine levels in human plasma using LC-MS/MS and clinical application to Chinese children with ADHD based on CPIC guidelines

Published:2021 Issue:21 Volume:13 Page:2434-2441
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Xia Ying¹²³⁴⁵^ORCID,Guo Hong-Li¹²³⁴⁵^ORCID,Hu Ya-Hui¹²³⁴⁵^ORCID,Long Jia-Yi¹²³⁴⁵,Chen Jing⁶³⁴⁵,Chen Feng¹²³⁴⁵^ORCID,Ji Xing¹²³⁴⁵^ORCID

Affiliation:

1. Pharmaceutical Sciences Research Center

2. Department of Pharmacy

3. Children's Hospital of Nanjing Medical University

4. Nanjing 210008

5. China

6. Department of Neurology

Abstract

This paper focuses on the determination of atomoxetine in human plasma. The work can provide therapeutic recommendations regarding atomoxetine and help clinicians in dose optimization.

Funder

Jiangsu Provincial Commission of Health and Family Planning

Nanjing Medical University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Chemical Engineering,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/AY/D1AY00521A

Reference20 articles.

1. The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

2. Attention-Deficit/Hyperactivity Disorder, Its Pharmacotherapy, and Adrenal Gland Dysfunction: A Nationwide Population-Based Study in Taiwan

3. Atomoxetine: a novel treatment for child and adult ADHD

4. A critical appraisal of atomoxetine in the management of ADHD

5. Clinical Pharmacokinetics of Atomoxetine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a fluorescent nano-sensing probe for atomoxetine analysis: Additional clinical pharmacokinetic study;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-12

2. Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review;Frontiers in Public Health;2024-08-07

3. Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together;Translational Psychiatry;2024-03-19

4. LC-MS/MS assay for the therapeutic drug monitoring of perampanel in children with drug-resistant epilepsy;Acta Chromatographica;2023-04-25

5. Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence;European Journal of Clinical Pharmacology;2023-01-16